Respiratory Infection Clinical Trials

6 recruiting

Respiratory Infection Trials at a Glance

37 actively recruiting trials for respiratory infection are listed on ClinicalTrialsFinder across 6 cities in 57 countries. The largest study group is Not Applicable with 10 trials, with the heaviest enrollment activity in Melbourne, Perth, and Brisbane. Lead sponsors running respiratory infection studies include Australian and New Zealand Intensive Care Research Centre, Valenta Pharm JSC, and BioFire Defense LLC.

Browse respiratory infection trials by phase

Treatments under study

About Respiratory Infection Clinical Trials

Looking for clinical trials for Respiratory Infection? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Respiratory Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Respiratory Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 37 trials

Recruiting
Not Applicable

Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial

Acute Respiratory Infections (ARIs)
BioMérieux800 enrolled2 locationsNCT07513519
Recruiting
Phase 2

Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.

PneumoniaRespiratory InfectionAcute Respiratory Distress Syndrome+3 more
Vasomune Therapeutics, Inc.120 enrolled5 locationsNCT05123755
Recruiting
Phase 2

A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age

Viral Respiratory InfectionViral Respiratory Illnesses
ENA Respiratory Pty Ltd1,100 enrolled5 locationsNCT07222670
Recruiting
Not Applicable

Effectiveness and Implementation of a National Guideline for Acute Respiratory Tract Infections to Reduce Antibiotic Prescribing in Swiss Primary Care

Acute Respiratory Infection
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland200 enrolled1 locationNCT07396428
Recruiting
Not Applicable

ORCHARDS-AIR Study

Acute Respiratory Infection
University of Wisconsin, Madison422 enrolled1 locationNCT07298967
Recruiting
Not Applicable

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care

AnginaAcute BronchiolitisAcute Bronchitis+8 more
University Hospital, Caen4,500 enrolled1 locationNCT07359287
Recruiting
Not Applicable

Artificial Intelligence Diagnostic Decision Support to Reduce Antimicrobial Prescriptions in Young Children With Colds

Acute Otitis Media (AOM)Upper Respiratory Infection
Timothy Shope300 enrolled2 locationsNCT06876259
Recruiting
Phase 1Phase 2

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Cystic Fibrosis LungRespiratory Infections, Recurrent, Chronic
Respirion Pharmaceuticals Pty Ltd72 enrolled22 locationsNCT06016088
Recruiting

The Fever Clinic Acute Respiratory Cohort

Community-acquired PneumoniaFebrile IllnessesViral Respiratory Tract Infections+1 more
Fudan University1,000 enrolled1 locationNCT07278700
Recruiting
Phase 4

Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs).

Respiratory InfectionLower Respiratory Tract Infection (LRTI)
Laboratorio Farmaceutico SIT srl240 enrolled10 locationsNCT06736288
Recruiting
Not Applicable

Efficacy of Ultraviolet Germicidal Irradiation Devices to Reduce Respiratory Infections in Nursing Homes: Cluster Randomized Crossover Trial

Acute Respiratory Infections
Centre Hospitalier Emile Roux1,200 enrolled12 locationsNCT06569160
Recruiting

Cohort Study of Arbovirus and Other Emerging Virus Infections in Fiji: AEVI-Fiji Cohort.

Respiratory Infection VirusArbovirus Infections
Fiji National University910 enrolled1 locationNCT07229677
Recruiting

Preparedness Through Respiratory Virus Epidemiology and Community Engagement

Respiratory Infection Virus
University of California, San Diego25,000 enrolled2 locationsNCT07147517
Recruiting

FebriDx® Pediatric Validation Study

Acute Respiratory Infections (ARIs)
Lumos Diagnostics800 enrolled10 locationsNCT07211997
Recruiting

Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses

CoronavirusCOVIDRespiratory Infection
BioFire Defense LLC1,500 enrolled6 locationsNCT07221097
Recruiting

Impact of the Presence of Anti-interferon Autoantibodies on the Viral Load in Severe Respiratory Infections

Severe Respiratory Infections
Hospices Civils de Lyon360 enrolled3 locationsNCT05536219
Recruiting
Phase 2

Omalizumab Before Onset of Exacerbations

Asthma in ChildrenAtopyViral Upper Respiratory Infection
Children's National Research Institute300 enrolled1 locationNCT05332067
Recruiting
Phase 1

Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers

InfluenzaViral Respiratory Infection
Valenta Pharm JSC36 enrolled1 locationNCT06859333
Recruiting

Respiratory Virus Metagenomics After COVID-19

COVID-19 Respiratory Infection
Chinese University of Hong Kong500 enrolled1 locationNCT05126589
Recruiting
Phase 2Phase 3

Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness

COVID-19 Respiratory Infection
Peking Union Medical College Hospital1,096 enrolled1 locationNCT05689034